Can MRI Provide Reliable Biomarkers for Autism Spectrum Disorder?

Can MRI Provide Reliable Biomarkers for Autism Spectrum Disorder?

Madeleine Haase

April 07, 2022

1

The study covered in this summary was published on MedRxiv.org as a preprint and has not yet been peer reviewed.

Key Takeaways

  • MRI provides an important source of information for the study of autism spectrum disorder (ASD).

  • Predictive MRI biomarkers enable longitudinal follow-ups and prospective epidemiology. 

  • Infants at risk for ASD could be scanned longitudinally, which could allow us to develop early biomarkers useful when behavior is not a sufficient basis for diagnosis.

Why This Matters

  • Autism spectrum disorder is a lifelong neurodevelopmental disorder that affects more than 1% of the population.

  • MRI is an important tool to explore the brain of individuals with ASD, as it is a widely available, fast, and non-invasive method to measure brain anatomy and function.

  • MRI has been extensively used to identify anatomical and functional differences in ASD. However, many of these findings have proven difficult to replicate because studies rely on small cohorts and are built on many complex, undisclosed, analytic choices.

Study Design

  • Researchers launched a data-science prediction challenge, inviting data scientists to submit algorithms to predict ASD diagnostic from provided MRI data. The 10 best submissions were analyzed.

  • The algorithms were first applied to different imaging modalities: only functional MRI, or only anatomical MRI.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....